Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Loda

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|May 13, 2010
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancerL M Flores, D W Kindelberger, A H Ligon, et al.
Diseases of the Colon and Rectum|December 1, 1995
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinomaJ M Jessup, P T Lavin, C W Andrews, et al.
Oncogene|March 14, 2000
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancerZ Gu, G Thomas, J Yamashiro, et al.
Gut|January 13, 2006
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studiesS Ogino, M Cantor, T Kawasaki, et al.
Cancer Research|May 1, 1998
Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinomaS P Singh, J Lipman, H Goldman, et al.
Oncogene|June 20, 2012
The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradationZ Liu, S M Zanata, J Kim, et al.
The American Journal of Pathology|December 26, 2001
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colonT Hinoi, M Tani, P C Lucas, et al.
Journal of the National Cancer Institute|December 7, 2000
Her-2-neu expression and progression toward androgen independence in human prostate cancerS Signoretti, R Montironi, J Manola, et al.
Endocrine-Related Cancer|March 4, 2008
BRAF(V600E) mutation and the biology of papillary thyroid cancerF Frasca, C Nucera, G Pellegriti, et al.
British Journal of Cancer|September 3, 2010
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancerY Baba, K Nosho, K Shima, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|May 13, 2010
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancerL M Flores, D W Kindelberger, A H Ligon, et al.
Diseases of the Colon and Rectum|December 1, 1995
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinomaJ M Jessup, P T Lavin, C W Andrews, et al.
Oncogene|March 14, 2000
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancerZ Gu, G Thomas, J Yamashiro, et al.
Gut|January 13, 2006
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studiesS Ogino, M Cantor, T Kawasaki, et al.
Cancer Research|May 1, 1998
Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinomaS P Singh, J Lipman, H Goldman, et al.
Oncogene|June 20, 2012
The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradationZ Liu, S M Zanata, J Kim, et al.
The American Journal of Pathology|December 26, 2001
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colonT Hinoi, M Tani, P C Lucas, et al.
Journal of the National Cancer Institute|December 7, 2000
Her-2-neu expression and progression toward androgen independence in human prostate cancerS Signoretti, R Montironi, J Manola, et al.
Endocrine-Related Cancer|March 4, 2008
BRAF(V600E) mutation and the biology of papillary thyroid cancerF Frasca, C Nucera, G Pellegriti, et al.
British Journal of Cancer|September 3, 2010
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancerY Baba, K Nosho, K Shima, et al.
Pageof 11